The United Laboratories International Holdings (3933) Stock Statistics & Valuation Metrics

The United Laboratories International Holdings has a market cap or net worth of HK$17.52B. The enterprise value is HK$8.96B.

The United Laboratories International Holdings has 1,973,026,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

The United Laboratories International Holdings’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.15%.

The current PE Ratio of The United Laboratories International Holdings is 9.4. The United Laboratories International Holdings’s PEG ratio is -0.39.

In the last 12 months, The United Laboratories International Holdings had revenue of 13.21B and earned 2.09B in profits. Earnings per share was 1.11.

In the last 12 months, operating cash flow was 1.76B and capital expenditures -1.14B, giving a free cash flow of 620.04M billion.

The United Laboratories International Holdings pays an annual dividend of HK$0.175, resulting in a dividend yield of 5.11%

The United Laboratories International Holdings upcoming earnings date is Aug 27, 2026, TBA (Confirmed).

The United Laboratories International Holdings as a current ratio of 1.83, with Debt / Equity ratio of 28.70%

In the past 12 months, The United Laboratories International Holdings has paid 446.87M in taxes.

The United Laboratories International Holdings EV to EBITDA ratio is 4.72, with an EV/FCF ratio of 15.64.

The United Laboratories International Holdings has HK$11.24B in cash and marketable securities with HK$4.99B in debt, giving a net cash position of HK$6.25B billion.

Gross margin is 41.74%, with operating margin of 17.20%, and net profit margin of 15.79%.

The average price target for The United Laboratories International Holdings is HK$16.23, which is 11.43% higher than the current price. The consensus rating is Strong Buy